INTRODUCTION
Fine needle aspiration cytology (FNAC), a technique for obtaining cellular material for cytological examination and diagnosis using a 21-gauge or smaller needle, is performed using a 5, 10, or 20ml syringe either freehand or using special syringe holders. It allows a minimally invasive, rapid diagnosis of tissue samples but does not preserve its histological architecture. Although exfoliative cytology (i.e. Pap smear) is universally accepted and used in Nigeria, aspiration cytology has yet to be widely accepted as a method of microscopic diagnosis. These two techniques differ in their aim. Exfoliative cytology is used primarily to detect precancerous and cancerous conditions that are not yet clinically apparent, aspiration cytology is used to determine the nature of clinically detectable tumours. The advantages of FNAC are innumerable and these include cost effectiveness, rapid reporting and bedside diagnosis, minimal physical and psychological discomfort, elimination of a two-stage procedure for diagnosis and treatment, active participation of the patient in treatment planning, and serving as a therapeutic procedure for evacuation of cystic lesions 1, 2 
• Rapid reporting and bedside diagnosis of neoplastic, hyperplastic, and inflammatory masses.
• Active participation of the patient in treatment planning and provides opportunity for fuller preoperative counselling.
• Elimination of a two stage procedure.
• Therapeutic procedure for the evacuation of cystic lesions.
• Allows cases to be prioritized when there is a waiting time for surgery • Permits the diagnosis of some benign conditions for which there is no need for surgery.
• Renders unnecessary the need for excision biopsy in advanced disease, elderly patients, or in cases where the treatment is non-surgical, e.g. in neoadjuvant chemotherapy.
• It is a rapid means of confirmation of recurrence of previously treated malignancy without surgery 2 . 
LIMITATIONS

COMPLICATIONS
Complications are few and seldom serious. The incidence of major complications reported is well below 1% and generally in the range of 0.05% 5 . Serious complications include:
1. HAEMORRHAGE Serious haemorrhages have only been reported after FNA of deep structures such as the lung, liver, and kidney. Bleeding from CT scan-guided FNA of retroperitoneal adenopathy is reported at less than 1% despite the proximity to great vessels. 5 Haematoma formation is unpredictable but can be minimized by prolonged pressure following aspiration, but sometimes the bleeding occurs very rapidly even before the needle is withdrawn. This can obscure the lesion and make a second aspiration difficult or impossible. It may render mammograms difficult to interpret for the following two weeks; hence it is recommended that all imaging investigations should be completed before FNA
PNEUMOTHORAX:
This is a rare complication found mainly in women with small breasts, in medial lesions or when sampling axillary lymph nodes. Large pneumothoraces are obvious, but small ones may go undetected. Clues such as sharp pain, coughing, or a hiss of air on withdrawing the needle without evidence of air in the syringe may occur. 10 
VASOVAGAL REACTIONS
These range in severity from mild lightheadedness to syncope.
SEEDING OF TUMOUR
Despite the persistent fears of clinicians that 'needling' a malignancy may result in dissemination, there is no evidence that this occurs with breast FNA 11 .
5
. PAIN This is common on FNA but is transitory and is not usually severe. Aspiration from painful areas of benign breast change is sometimes associated with some pain. Carcinomas, particularly those with abundant fibroelastotic stroma, are often painful and this can be a guide to the aspirator that the needle has hit the lesion.
PITFALLS IN FNAC
Pitfalls are common in all aspects of diagnostic FNAC. There are many different kinds of pitfalls and they occur in many different contexts. Some pitfalls are the result of factors related to the sampling procedure. Others are created by unusual microarchitectural features or by the appearance of the cellular or stromal components specific to the lesion being investigated. 9, 12 Errors in diagnosis of lesions can lead to over-treatment or delay in diagnosis and treatment. Aspiration cytology requires highly skilled and trained personnel in both aspiration and assessment. Stewart commented in 1933 that "until the pathologist has familiarized himself with the various pitfalls, errors are certain to occur" and "it must not be inferred that the diagnosis is always simple and that no errors have been made" 7 . For this reason, FNAC must always be interpreted in association with clinical and radiological opinions in the triple approach. The NHSBSP Cytology Guidelines also state that "under no circumstances should a cytological opinion of malignancy in the absence of mammographic and / or clinical evidence of malignancy be taken as authority for therapeutic surgery" 'Intrinsic' factors which can lead to diagnostic pitfalls result in false positive or false negative diagnosis arise mainly due to deviations from general cytodiagnostic criteria which can occur in a variety of nonneoplastic and neoplastic lesions in different sites. The deviations may concern the microarchitectural pattern, the cellular composition or the stromal component of the target tissue. Pitfalls are an inseparable part of the practice of FNAC, but its occurrence can be minimized if the requisite diagnostic rigours are applied and care taken to correlate cytology with clinical history and with clinical and radiological findings. Multiple sampling used liberally when indicated, independent double checking by two pathologists of all primary malignant diagnoses and most importantly experience acquired from frequent usage of this technique help to minimize the incidence of diagnostic pitfalls in FNA cytodiagnosis.
FNAC IN UBTH
The popularity of FNAC in UBTH has been on the increase since the procedure was introduced to the hospital in the early 2000s. But it was been used rather sparingly as attested to by the fact that for the whole of the year 2003 only 5 FNACs were performed (all for breast masses). Most of which were for cases that were obviously clinically malignant. The surgeons were in these cases, for medico-legal reasons, looking for pathological justification to perform therapeutic surgery without necessarily subjecting the patient to two surgeries. The reasons for this initial apathy are manifold but were mostly centred on the reliability of the test result, the added cost implication to the patients and the timeliness of the result. After some of these fears and reservations were allayed, the procedure has gained currency among surgeons in UBTH to the extent that in the year 2005 the number of FNAC done for breast masses alone had risen to 103.
This has led to the setting up of a dedicated FNAC clinic in the department of pathology. In addition to breast lumps, other sites frequently aspirated in the clinic includes superficial lymph node enlargement, thyroid gland masses and salivary gland masses. In breast aspirates, where the most experience has been acquired over the past 3-4 years, we have been able to demonstrate that our results are most reliable. In the period between January 2005 and March 2006 absolute and complete sensitivity of 84.6% and 97.4% respectively were achieved. The specificity was 64%, positive predictive value for malignancies was 100%, and there was an inadequate rate of 19.4%. 
